Genome & Company (314130) - Financials, balance sheet (annual)

2,540 KRW

0.78%

Last update Aug 29, 3:00 PM KST

Post-market

Day range

2,540

2,530

2,585

Previous close

2,560

Open

2,565

Access this stock data via API

Genome & Company

2,540.00

0.78%

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	147.3B	162.1B	173.0B	137.2B
Current assets	91.9B	97.0B	116.9B	81.8B
Cash	—	—	—	593K
Cash equivalents	65.5B	56.4B	72.2B	36.0B
Cash and cash equivalents	65.5B	56.4B	72.2B	36.0B
Other short term investments	15.4B	29.9B	34.5B	41.1B
Accounts receivable	2.1B	1.4B	2.0B	759.2M
Other receivables	2.0B	2.1B	1.4B	1.3B
Inventory	5.8B	3.6B	2.2B	1.3B
Prepaid assets	939.3M	1.4B	1.3B	1.2B
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	276.8M	2.3B	3.3B	—
Other current assets	-300	-480	-290	-100
Non current assets	55.4B	65.0B	56.1B	55.4B
Properties	3.8B	4.6B	6.1B	7.1B
Land and improvements	2.7B	2.7B	10.6M	—
Machinery furniture equipment	33.0B	27.7B	26.9B	16.4B
Construction in progress	2.5B	8.5B	4.2B	2.3B
Leases	—	—	—	—
Accumulated depreciation	-23.4B	-18.1B	-15.7B	-9.2B
Goodwill	36.5B	39.4B	46.8B	51.3B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	8.3B	11.1B	13.9B	18.4B
Investments and advances	—	—	—	—
Other non current assets	720	140	-1.2K	-630
Total liabilities	48.3B	48.5B	22.5B	23.8B
Current liabilities	29.8B	28.2B	11.1B	9.8B
Accounts payable	481.2M	340.2M	205.2M	321.4M
Accrued expenses	—	—	—	—
Short term debt	19.6B	13.1B	2.0B	1.6B
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	212.7M	160.4M	183.8M	147.4M
Other current liabilities	-2.1K	600	-140	610
Non current liabilities	18.5B	20.3B	11.3B	14.0B
Long term provisions	36.0M	132.1M	154.5M	240.0M
Long term debt	12.4B	13.4B	4.3B	5.2B
Provision for risks and charges	—	—	—	83.4M
Deferred liabilities	3.2B	4.4B	5.6B	6.8B
Derivative product liabilities	—	15.5M	—	1.2B
Other non current liabilities	—	-290	110	170
Shareholders equity
Common stock	15.5B	7.4B	7.0B	7.0B
Retained earnings	-304.8B	-284.7B	-237.2B	-185.4B
Other shareholders equity	—	—	—	—
Total shareholders equity	99.1B	113.5B	150.5B	113.4B
Additional paid in capital	296.5B	304.8B	304.7B	257.3B
Treasury stock	—	—	—	—
Minority interest	50.8B	51.1B	53.2B	20.7B